Publication:
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.

dc.contributor.authorJiménez, David
dc.contributor.authorde Miguel-Díez, Javier
dc.contributor.authorGuijarro, Ricardo
dc.contributor.authorTrujillo-Santos, Javier
dc.contributor.authorOtero, Remedios
dc.contributor.authorBarba, Raquel
dc.contributor.authorMuriel, Alfonso
dc.contributor.authorMeyer, Guy
dc.contributor.authorYusen, Roger D
dc.contributor.authorMonreal, Manuel
dc.contributor.authorRIETE Investigators
dc.date.accessioned2023-01-25T08:30:40Z
dc.date.available2023-01-25T08:30:40Z
dc.date.issued2016
dc.description.abstractDespite advances in hospital management in recent years, it is not clear whether mortality after acute pulmonary embolism (PE) has decreased over time. This study describes the trends in the management and outcomes of acute symptomatic PE. We identified adults with acute PE enrolled in the registry between 2001 and 2013. We assessed temporal trends in length of hospital stay and use of pharmacological and interventional therapies. Using multivariable regression, we examined temporal trends in risk-adjusted rates of all-cause and PE-related death to 30 days after diagnosis. Among 23,858 patients with PE, mean length of stay decreased from 13.6 to 9.3 days over time (32% relative reduction, p  In a large international registry of patients with PE, improvements in length of stay and changes in the initial treatment were accompanied by a reduction in short-term all-cause and PE-specific mortality.
dc.identifier.doi10.1016/j.jacc.2015.10.060
dc.identifier.essn1558-3597
dc.identifier.pmid26791063
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.jacc.2015.10.060
dc.identifier.urihttp://hdl.handle.net/10668/9754
dc.issue.number2
dc.journal.titleJournal of the American College of Cardiology
dc.journal.titleabbreviationJ Am Coll Cardiol
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number162-170
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectheparin
dc.subjectlength of stay
dc.subjectoutcomes
dc.subjectprognosis
dc.subjectsurgical embolectomy
dc.subjectsurvival
dc.subjectthrombolysis
dc.subject.meshAcute Disease
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshDisease Management
dc.subject.meshFemale
dc.subject.meshFibrinolytic Agents
dc.subject.meshHeparin, Low-Molecular-Weight
dc.subject.meshHumans
dc.subject.meshLength of Stay
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshOutcome and Process Assessment, Health Care
dc.subject.meshPrognosis
dc.subject.meshPulmonary Embolism
dc.subject.meshRisk Assessment
dc.subject.meshSpain
dc.subject.meshSurvival Analysis
dc.subject.meshThrombectomy
dc.subject.meshThrombolytic Therapy
dc.titleTrends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number67
dspace.entity.typePublication

Files